Seppic Triples Ceramosides Capacity at 1,400 m² Lons Unit

October 30, 2026

A 1,400 m² production unit triples Ceramosides capacity at Seppic’s Lons site near Pau, France.
The wheat-derived phytoceramide range is used in oral nutrition and topical beauty products.

Seppic, a France-based specialty ingredient producer, inaugurated a 1,400 m² production unit at its Lons site near Pau on October 27. The addition triples manufacturing capacity for Ceramosides, its wheat-derived phytoceramide range used across nutrition and beauty applications.

The building sits within an eight-hectare site that employs more than 50 people. Seppic said the unit expands output of purified natural active ingredients, with Ceramosides available for both oral and topical formulations. The company did not provide the site’s previous or new annual throughput.

The Lons site contains three manufacturing units and laboratories for botanical ingredient innovation. Its operations cover purified natural actives for supplement, cosmetic and pharmaceutical applications, allowing the new unit to build on existing extraction and quality-control infrastructure.

Ceramosides is already identified on the packaging of more than 150 nutrition brands worldwide, according to Seppic. The range is positioned for skin hydration, anti-aging and hair-health applications, connecting the production increase directly to ingestible beauty and supplement customers rather than a general-purpose plant expansion.

Seppic did not disclose the project’s investment value or a separate commissioning timetable. CEO Virginie Cavalli described the new unit as a response to customer demand while broadening the activities handled at Lons.